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Abstract 
 
 
Background: Little is known about compliance with colonoscopy as a screening method in 
first-degree relatives of patients with large adenomas. 
Aims: To evaluate the compliance with screening colonoscopy among this population, and its 
determinants. 
Methods: Data were obtained from the family part of the GEADE study, a study on genetic 
factors of colorectal adenomas. Index cases were 306 patients with adenomas ≥ 10mm. All 
living first-degree relatives aged 40-75 who could be contacted by the index case were invited 
to undergo a colonoscopy, unless they had had one in the previous 5 years.  
Results: Among 674 eligible relatives, 56 had had a colonoscopy within the preceding 5 
years and 114 underwent a screening colonoscopy resulting in a compliance with screening 
colonoscopy of 18%. This was not related to most characteristics of index cases. Compliance 
was significantly lower when the index case lived in the Greater Paris area than when he/she 
lived in other areas (12% vs 21%). It was higher in siblings (18%) and offspring (23%) than in 
parents (9%) and in relatives under 55 years old (22%) than in relatives aged 55 and over 
(15%). 
Conclusions: Compliance with colonoscopy was low in first-degree relatives of patients with 
large adenomas. The reasons should be determined and appropriate strategies developed to 
increase compliance. 
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Colorectal cancer is one of the most frequent cancers in developed countries. In France, 
it ranks third with 36,250 new cases in 2000 (1). Most cancers arise from colorectal adenomas 
which have high malignant potential when they are ≥ 10mm in diameter and/or present severe 
dysplasia and villous component. Endoscopic detection and removal of adenomas is therefore 
recommended in order to reduce the risk of colorectal cancer in affected patients (2).  
An increased risk of colorectal cancer and adenomatous polyps in the family members 
of patients with colorectal cancer has already been demonstrated (3,4). The association 
between the risk of developing colorectal tumours and family history of large adenomas in 
first-degree relatives has not been so extensively studied (5-8). A systematic review of 9 
studies published between 1984 and 1998 estimated the relative risk of colorectal cancer 
associated with history of adenomas in relatives as 2 (95%CI=2-3) (3). All these studies used 
a case-control design and compared the frequency of family history of colorectal cancer in 
adenoma cases with polyp-free or population controls. These studies might be subject to recall 
biases and could not be used to quantify the risk of colorectal adenomas in relatives of 
adenoma patients. 
Whereas professional bodies usually recommend colonoscopic screening in relatives of 
patients with colorectal cancer, screening modalities for relatives of patients with high-risk 
adenomas are debated. In 1998, the French consensus conference on colorectal cancer 
concluded that the scientific evidence was not sufficient to establish guidelines for these 
patients (9). According to more recent French recommendations, individuals with a family 
history of colon cancer or adenomas diagnosed in first-degree relatives under 60 years old 
should be advised to have screening colonoscopy from the age of 45, or 5 years younger than 
the earliest diagnosis in their family (10). No recommendations were proposed for individuals 
with first-degree relatives diagnosed with colorectal cancer after 60. In the same way, the 
American guidelines recommend colonoscopy at 40, or 10 years before the index case for 
individuals with a strong family history of colorectal cancer or polyps (11,12).  
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Colonoscopy is an expensive and invasive screening method which carries some risk for 
the patient and thus, may not be appropriate in populations with a moderately increased risk 
of colorectal cancer. Furthermore, its acceptability in such populations is debatable. From a 
public health point of view, participation rate is one of the key factors likely to affect the 
effectiveness of a screening method on the reduction of colorectal cancer mortality or 
incidence in a given population.  
Because of the scarcity of data about this topic, the present analyses, based on the data 
from the GEADE study, aimed at assessing compliance with colonoscopy as a screening 
method among first-degree relatives of patients with large adenomas and at examining some 
determinants of the compliance. 
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Patients and Methods 
The GEADE study is a French family and case-control study on genetic factors of 
colorectal adenomas. The primary aims were to compare the frequency of various 
susceptibility genes in patients with large adenomas (index cases) and in controls with small 
adenomas or free of adenomas, and to assess the risk of colorectal tumours in first-degree 
relatives of index cases compared to a reference population. The family part of this study gave 
us the opportunity of evaluating the compliance with colonoscopy in first-degree relatives 
with large adenomas and its determinants. 
The study was performed in 18 participating gastroenterology units in French non-
university hospitals with mixed urban/rural recruitment. They were located in small to 
medium-sized towns ( 6 towns were on a large area around Paris called ‘Greater Paris area’, 3 
on the Northeast, 2 on the southwest, 3 on the southeast and 4 on the centre of France). From 
September 1995 to March 2000, 306 consecutive patients with a newly diagnosed adenoma ≥ 
10mm were enrolled and referred as index cases. Subjects with a history of colorectal cancer 
or other cancer, familial adenomatous polyposis syndrome, established hereditary non-
polyposis colorectal cancer and inflammatory bowel disease were excluded. For all index 
cases, endoscopic and pathological records were obtained from participating centres. We also 
collected information about demographic data (age, gender, residence area), personal history 
of polyps, family history of colorectal cancer, indications of colonoscopy, completeness of 
colonoscopy and detailed characteristics of lesions removed (size, location, histologic type, 
histologic architecture, degree of dysplasia). Lesion location was defined as distal (including 
rectum, rectosigmoid, sigmoid, descending colon, and splenic flexure) and proximal 
(including transverse colon, hepatic flexure, ascending colon and caecum). 
All index cases belonged to independent families. Two hundred and sixty-seven (89%) 
index cases consented to a family investigation. Information on all first-degree relatives 
(parents, siblings and offspring) was obtained during a face-to-face interview between the 
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gastroenterologist and the index cases. Family data included demographic and medical 
characteristics of each relative such as name, date of birth and/or age, residence area, vital 
status, cause and age at death if applicable, history of polyps or cancer. 
As indicated in Figure 1, 1763 first-degree relatives were identified among whom 550 
were deceased. According to French ethical rules, no direct contact between investigators and 
relatives of the patients is allowed. Thus, during a special consultation, the study was 
explained to the index cases who were asked to contact their relatives and to pass on an 
explanatory booklet. This contained a general introductory letter describing briefly the aims 
of the study and its implementation, a general leaflet about colorectal cancer (edited 
previously by the Ligue Nationale Contre le Cancer), an informed consent sheet explaining 
the advantages and potential drawbacks of colonoscopy and a health study questionnaire to 
return. Finally, information about the genetic part of the study was given together with a 
specific informed consent form, tubes for blood sampling and a letter for the customary 
laboratory used by the relative.  
If the relatives were aged 40-75 and had not had an examination during the preceding 5 
years, they were invited to consult their general practitioner in order to discuss the indications 
for colonoscopy, and to be addressed to a gastroenterologist of their choice to perform the 
examination, standard letters to them being attached to booklet. There was no a priori 
exclusion of patients with prior history of cancer or bowel resection.  
Index cases refused to contact 85 relatives (7.0%) for the following reasons: old age 
(n=3) or poor health of the relatives (n=8), family dissensions (n= 38), relatives living too far 
away (n=34) or unknown reasons (n=2). Three hundred and twenty relatives out of 1120 
living first-degree relatives who could be contacted, returned the health study questionnaire 
(29%), gathering information about possible previous colonoscopies and the name and 
address of the general practitioner. Whether colonoscopy was performed before or after that 
of the index case, details about endoscopic findings were obtained from the relative’s 
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gastroenterologist for 94% of the participating subjects. No endoscopic report could be 
obtained for ten relatives: eight subjects declared that no lesion was discovered during their 
colonoscopy and two did not know the results of the colonoscopy.  
All index patients and first-degree relatives gave their informed consent. The research 
protocol was approved by the ethics committee of Kremlin-Bicêtre hospital. 
Age of the index case and of relatives was considered as a two-category variable. 
Because French guidelines recommend a colonoscopy for first-degree relatives of patients 
affected before 60 years, a cut-off of 60 years was used for the index case. A cut-off of 55 
years corresponding to the approximate median was used for the first-degree relatives. 
Residence proximity between the index case and relatives was defined as residence in the 
same administrative area or in bordering areas. Associations between compliance with 
colonoscopy among first-degree relatives and the characteristics of index case or the 
characteristics of relatives were evaluated by population-averaged logit models using 
generalized estimating equations (13). The generalized estimating equations method allows 
simultaneous analysis of data regarding index cases and relatives, and takes into account both 
intra-familial correlations and family size. The exchangeable correlation structure was the 
most appropriate for such clustered observations, because there was no logical ordering for 
family members within a family cluster. Moreover, it was the most neutral option. All 
variables related to colonoscopy compliance with a significance level < 0.15 were considered 
in the multivariate analysis. All statistical analyses were performed using STATA software 
(StataCorp: Stata Statistical Software: Release 7.0. College Station, TX, Stata Corporation, 
2001). Odds ratios (OR) are presented with their corresponding 95% confidence intervals 
(95% CI). Intra-familial correlation of acceptance for screening was investigated by 
comparing the expected distribution of the number of colonoscopies performed among 
families under the assumption of absence of intra-familial correlation (equal probability of 
acceptance among all relatives) to the observed one. Under this assumption, the distribution 
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of colonoscopies within families is simply a binomial one depending only on compliance rate 
and family size, and the number of expected colonoscopies can be computed for each family 
size from the average compliance rate, and then summed over all families.  
 
Results 
Three hundred and six eligible patients with an adenoma ≥ 10mm were enrolled as index 
cases. Colonoscopy was complete in 301 of them (98%), did not reach the caecum in 3 cases, 
and was completed by a double-contrast barium enema in 2 cases. The main characteristics of 
index cases are indicated in Table 1. The mean age of the patients was 62 years (standard 
deviation=13), and 63% were men. Forty-two (14%) had a personal history of polyps and 65 
(21%) had a family history of colorectal cancer. Index cases presented large adenomas on the 
distal colon in 83.3% of the cases, on the proximal colon in 11.4% and 5.2 % had on both 
locations. Most index cases (67.6%) had at least one adenoma with villous component and/or 
severe dysplasia or intramucosal carcinoma. 
As summarised in Figure 1, 39 of the 306 index cases did not have any family 
investigation. Characteristics of the index cases with and without family investigations were 
similar, except for gender. The family tree was more frequently drawn up for women than for 
men (93% vs. 84%, p=0.03).  
Among the 674 first-degree relatives eligible for screening colonoscopy, 170 relatives 
from 97 families underwent this examination, resulting in an overall proportion of subjects 
with colonoscopy of 25%. Fifty-six relatives had had a colonoscopy over the previous 5 years 
whereas 114 underwent a screening colonoscopy after the index case. Patients who had a 
screening colonoscopy were examined after a mean time period of 10.6 months (standard 
deviation=11.4). Among them, 49% and 74% underwent their colonoscopy respectively 
within 6 months and one year following the examination of the index case. None of the 
characteristics of first-degree relatives or index cases influenced this time period, except for 
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residence proximity. The time period for colonoscopy was longer for relatives residing near 
the index case than for those residing far away (p=0.02). 
After exclusion of 56 first-degree relatives who had had a colonoscopy within the 
preceding 5 years, the compliance rate for screening colonoscopy was 18% (114/618). 
Associations between first-degree relative’s characteristics and compliance are shown Table2. 
The compliance rate for colonoscopy was significantly higher in first-degree relatives under 
55 than in older subjects, in siblings and offspring than in parents of index cases, and tended 
to be higher in women than in men, but not significantly so.  
The Table 3 describes associations between index cases characteristics and compliance. 
The residence area of index cases was the only characteristic that significantly influenced the 
compliance of relatives with screening colonoscopy. Compliance was lower when the index 
cases lived in the Greater Paris area than when they lived in other areas. Compliance of 
relatives was not related to age, gender, family history of colorectal cancer, personal history 
of polyps and the presence of advanced adenomas among index cases. 
Because the age of relatives and their blood relationship with the index case were 
strongly related, these variables were separately introduced in two distinct multivariate 
regression models. Thus, in the first model, variables entered were residence area of index 
case, gender and age of relatives. The compliance with screening colonoscopy was lower for 
relatives of index case from Greater Paris area than for relatives of index cases from other 
areas (OR=0.5, 95% CI: 0.3-0.9, p=0.03). Although not significantly, women had a better 
compliance with colonoscopy than men, (OR=1.4, 95% CI: 0.9-2.2, p=0.10). The compliance 
was lower for relatives older than 55 years than for younger relatives (OR=0.6, 95% CI: 0.4-
1.0, p=0.03). A second model including relationship with index case instead of relative’s age 
showed very close results regarding the effect of residence area of index case and relative’s 
gender. In comparison with parents, the OR for siblings was 2.9 (95% CI: 0.9-9.1, p=0.06) 
and for offspring, 3.5 (95% CI: 1.1-11.4, p=0.04). 
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The 618 first-degree relatives eligible for screening colonoscopy were members of 218 
families. Among 73 families, one relative at least underwent the examination. As shown in 
table 4, there is a strong excess of families with no colonoscopy and with 2 or more 
colonoscopies and a consequent deficit of families with only one colonoscopy, which means 
that there is a high degree of intra-familial correlation of acceptance for screening (χ2 = 68; 
p<0.001). 
Colonoscopic findings could be obtained in 168 out of 170 first-degree relatives who 
participated in the study. Colorectal tumours were detected in 38 first-degree relatives (23%). 
The prevalence of cancers and adenomas was respectively 3 % and 20%. All cancers were 
found in relatives of index cases who presented advanced adenomas (villous component 
and/or severe dysplasia) of which two were also ≥ 20 mm in diameter. 
 
Discussion 
To our knowledge, this study was the first prospective study to examine compliance 
with colonoscopy among first-degree relatives of patients with large adenomas. The study 
showed that, in clinical practice, it was possible to contact, through the index case, the great 
majority of eligible relatives, in order to encourage them to have a colonoscopy. However, it 
also revealed a low compliance with screening colonoscopy, around 18%, among these 
subjects.  
Several strengths and limitations of the study should be emphasised. This study was 
performed in a large number of endoscopy units within general hospitals throughout the 
country. Eligible patients with large adenomas were prospectively and consecutively recruited 
after a complete colonoscopy was obtained. Thus, it is unlikely that major selection biases 
may have affected our study sample. Indeed, the distribution of age, gender and family history 
of colorectal cancer among patients with large adenomas was very close to that found in a 
previous French study (6). Furthermore, the family information was carefully collected 
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through a face-to-face interview by well-trained and motivated investigators according to a 
protocol similar to that used in a previous study carried out by our group (14). For the vast 
majority of relatives (94%) who participated in the study, colonoscopic findings were 
confirmed through endoscopic and pathological reports. These procedures give some 
guarantee about the reliability of information recorded for family members. The main 
limitation of the study lies in the fact that physicians were unable to directly contact patient’s 
relatives. According to French ethical rules, relatives can only be contacted by the index case. 
Although index cases were well aware of the importance for their relatives to undergo a 
colonoscopy, we cannot be sure that family members were really informed about the study 
and received the information booklet and consent form.  
Although investigators were highly motivated and, often, solicited index cases again 
when their relatives were non-compliant, the low rate of colonoscopy among relatives (18%) 
was disappointing. This suggests that compliance would be even lower in routine clinical 
practice. Compliance was lower than that found in a previous French study (39%) using the 
same design among relatives of patients with colorectal cancer (14). Other studies performed 
among relatives of patients with colorectal cancer showed large variations in compliance rates 
with colonoscopy ranging from 30% in Italy (15), 42% in United States (16), and 82% in 
Norway (17). The occurrence of colorectal cancer in first-degree relatives is probably a more 
worrying event than the occurrence of large adenomas probably considered as harmless 
lesions by most people. In this study, one third of the relatives had already undergone a 
colonoscopy over the previous 5 years. They were more often parents of the index case and 
presented a higher proportion of colorectal cancer (7%) than relatives who were examined 
after the index case (1%). It is possible in fact, that the cancer discovery in the first-degree 
relative led the index case to have an examination.  
Our study did not reveal any strong determinants of compliance with colonoscopy 
among relatives who underwent an examination after the index case. As observed in our 
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previous study among first-degree relatives of patients with colorectal cancer, our results 
suggest a lower acceptability of colonoscopy when the index case lived in the Greater Paris 
area (14). Both studies were based on patients recruited in French non-university hospitals. 
Thus, the extrapolation of our finding to subjects recruited in other clinical settings is 
uncertain. We have no reasons to suspect that investigators from this area were less actively 
involved in the study or less convincing among their patients than other investigators. 
Inhabitants of the Greater Paris area are known to be more highly mobile, to have a more 
stressful life with less free time, and family ties are probably less close than in other regions. 
Living conditions may partly explain the difficulty of obtaining the adherence of relatives to a 
screening programme in the Greater Paris area. In accordance with our previous observations 
among relatives of patients with colorectal cancer, age and blood relationships were the main 
characteristics for predicting their participation in screening colonoscopy. Compliance of 
relatives under 55 was better than that of older subjects and, accordingly, offspring and, to a 
lesser extent, siblings were more compliant than parents. Interestingly, this study showed the 
existence of a strong intra-familial correlation of acceptance for screening. This finding 
subsequently justifies the use of generalized estimation equations for the evaluation of 
determinants of compliance. Such a correlation may be the result of a higher motivation of 
individuals whose relative(s) already underwent screening colonoscopy, and/or familial 
characteristics, including educational and socioeconomic factors that could not be 
investigated in this study. 
The reasons why 80% of first-degree relatives did not participate in the study may be 
multiple. As less than 30% of the living relatives returned the questionnaire, it is possible that 
some of the remaining relatives were not informed by the index case. It is also possible that 
the information booklet was too complicated and could have discouraged the relatives from 
participating in the study. In addition, a previous study which focused on health beliefs 
suggested that first-degree relatives of patients with colorectal cancer did not perceive 
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themselves as being at risk for colorectal cancer (18). This behaviour is likely to be more 
pronounced in relatives of patients with pre-malignant colorectal lesions. The necessity of 
consulting a gastroenterologist in order to undergo embarrassing and uncomfortable 
procedures, the risk and cost of colonoscopy although it is almost totally reimbursed by the 
French health insurance system, and the fear of a lesion being discovered may also have 
discouraged family members. A thorough evaluation of sociological and psychological 
barriers in France would be necessary to understand the resistance of relatives to participation 
in screening programmes, and to improve their awareness about the seriousness of colorectal 
cancer and the benefits of screening. Potential targets for interventions to encourage relatives 
of colorectal cancer patients to have a colonoscopy have been identified in other countries 
(19,20). Interventions that aim at modifying perceived barriers and benefits of screening, that 
use family influences, particularly the affected member as a source of support, as well as 
physician influence may be possible ways to increase screening. Whether such interventions 
may be effective among relatives of patients with large adenomas in a European cultural 
background remains to be determined. 
The yield of colorectal tumours in first-degree relatives of patients with large adenomas 
seems to be comparable to that observed in relatives of patients with colorectal cancer. Using 
a similar design, our previous study showed a prevalence of cancer and adenomas of 
respectively 3% and  23% instead of 3% and 20% in the present study, suggesting that a 
family history of large adenomas carries a risk in first-degree relatives which is close  to that 
conferred by a family history of colorectal cancer (14).  
The low compliance rate with colonoscopy in the context of a family study leads to 
questioning about the most appropriate screening method in first-degree relatives of patients 
with large adenomas. The prevalence of large adenomas in the population is much higher than 
that of cancer so that a non-negligible proportion of the population may be concerned by 
screening measures. Faecal occult blood (FOB) testing is currently the only screening method 
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for which controlled trials demonstrated a reduction in colorectal cancer mortality in Europe 
(21-23) and the USA (24). Although the FOB test is well accepted in the population, its low 
sensitivity (around 60%) suggests that it is not very appropriate in a family context, except for 
subjects who refused colonoscopic screening (25). In populations at average or moderate risk, 
newer FOB immunochemical tests and computed tomographic virtual colonoscopy may be 
alternative techniques that require careful evaluation.  
In conclusion, the acceptability of colonoscopy is low in first-degree relatives of patients 
with large adenomas and only marginally influenced by the characteristics of relatives and 
index cases. Further studies are needed to better understand the reasons why members of 
some families are less compliant than others and to develop appropriate interventions to 
improve the acceptability of colonoscopy. 
 
 14
H
AL author m
anuscript    inserm
-00127338, version 1
Source of support:  
The study was supported by grants from the Fondation de France, the French National Society 
of Gastroenterology, the Ligue Nationale contre le Cancer (France), the Association pour la 
Recherche sur le Cancer, the Regional Council of Burgundy and the French Ministry of 
Health (PHRC). 
 
References 
 
 
1  Bouvier AM, Remontet L, Jougla E, et al. Incidence of gastrointestinal cancers in 
France. Gastroenterol Clin Biol 2004;28:877-81. 
2  Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by 
colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 
1993;329:1977-81. 
3  Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal 
cancer risk. Am J Gastroenterol 2001;96:2992-3003. 
4 Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal 
cancer for individuals with a family history: a meta-analysis. Eur J Cancer 
2006;42:216-27. 
5  Ahsan H, Neugut AI, Garbowski GC, et al. Family history of colorectal adenomatous 
polyps and increased risk for colorectal cancer. Ann Intern Med 1998;128:900-5. 
6  Boutron MC, Faivre J, Quipourt V, et al. Family history of colorectal tumours and 
implications for the adenoma-carcinoma sequence: a case control study. Gut 
1995;37:830-4. 
7  Nakama H,Fukazawa K. Colorectal cancer risk in first-degree relatives of patients 
with colorectal adenomatous polyp. Hepatogastroenterology 2002;49:157-9. 
 15
H
AL author m
anuscript    inserm
-00127338, version 1
8  Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of 
patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 
1996;334:82-7. 
9  [Consensus conference: Prevention Screening and Management of the Colonic 
Cancers. Paris, France, January 29-30, 1998. Proceedings]. 1998. Paris, France. 
Gastroenterol Clin Biol;22:S1-295. 
10  Endoscopie digestive basse: Indications en dehors de dépistage en population. 
Recommendations pour la pratique clinique. 2004 
http://www.anaes.fr/anaes/presse.nsf/(ID)/F4776FAB76041931C1256EC8005003B2?
opendocument.  
11  Smith RA, Cokkinides V,Eyre HJ. American Cancer Society guidelines for the early 
detection of cancer, 2004. CA Cancer J Clin 2004;54:41-52. 
12  Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: 
clinical guidelines and rationale-Update based on new evidence. Gastroenterology 
2003;124:544-60. 
13  Zeger SL, Liang KY,Albert PS. Models for longitudinal data: a generalized estimating 
equation approach. Biometrics 1988;44:1049-60. 
14  Pariente A, Milan C, Lafon J, et al. Colonoscopic screening in first-degree relatives of 
patients with 'sporadic' colorectal cancer: a case-control study. The Association 
Nationale des Gastroenterologues des Hopitaux and Registre Bourguignon des 
Cancers Digestifs (INSERM CRI 9505). Gastroenterology 1998;115:7-12. 
15  Colombo L, Corti G, Magri F, et al. Results of a pilot study of endoscopic screening of 
first degree relatives of colorectal cancer patients in Italy. J Epidemiol Community 
Health 1997;51:453-8. 
 16
H
AL author m
anuscript    inserm
-00127338, version 1
16  Guillem JG, Forde KA, Treat MR, et al. Colonoscopic screening for neoplasms in 
asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective 
study. Dis Colon Rectum 1992;35:523-9. 
17  Sauar J, Hausken T, Hoff G, et al. Colonoscopic screening examination of relatives of 
patients with colorectal cancer. I. A comparison with an endoscopically screened 
normal population. Scand J Gastroenterol 1992;27:661-6. 
18  Jacobs LA. Health beliefs of first-degree relatives of individuals with colorectal cancer 
and participation in health maintenance visits: a population-based survey. Cancer 
Nurs 2002;25:251-65. 
19  Madlensky L, Esplen MJ, Gallinger S, et al. Relatives of colorectal cancer patients: 
factors associated with screening behavior. Am J Prev Med 2003;25:187-94. 
20  Manne S, Markowitz A, Winawer S, et al. Understanding intention to undergo 
colonoscopy among intermediate-risk siblings of colorectal cancer patients: a test of a 
mediational model. Prev Med 2003;36:71-84. 
21  Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by 
fecal occult blood screening in a French controlled study. Gastroenterology 
2004;126:1674-80. 
22  Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of 
faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7. 
23  Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal 
cancer with faecal-occult-blood test. Lancet 1996;348:1467-71. 
24  Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by 
screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J 
Med 1993;328:1365-71. 
25  Jouve JL, Remontet L, Dancourt V, et al. Estimation of screening test (Hemoccult) 
sensitivity in colorectal cancer mass screening. Br J Cancer 2001;84:1477-81. 
 17
H
AL author m
anuscript    inserm
-00127338, version 1
Figure1: Study profile 
 
 
306 index cases with adenoma ≥ 10mm 
 
   
 
 
267 index cases  
  
 
 
 
1763 first-degree relatives 
 
 
 
   
 
 
1120        320 returned health study questionnaires 
 
 
      
   
         
 
  25 age unknown 
326 < 40 years old 
  95 > 75 years old 
550 deceased 
    8 with vital status unknown 
  85 without contact with the index case
39 without family investigation 
 
674 first-degree relatives [40-75] years old from 230 invited families  
 
   
 
 
56 first-degree relatives with colonoscopy in the preceding 5 years 
618 first-degree relatives [40-75] years old, eligible for screening colonoscopy  
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Table 1: Characteristics of 306 patients with large adenoma (index cases). 
  n % 
women  113 (36.9) Gender men 193 (63.1) 
< 60 years 123 (40.2) Age ≥ 60 years 183 (59.8) 
Greater Paris area 80 (26.1) Residence area other regions 226 (73.9) 
yes 65 (21.4) Family history of  
colorectal cancer † no 239 (78.6) 
yes 42 (13.7) Personal history of polyps 
no 264 (86.3) 
yes 71 (23.2) Rectal adenomas 
no 235 (76.8) 
yes 231 (75.5) Distal adenomas 
no 75 (24.5) 
yes 84 (27.4) Proximal adenomas 
no 222 (72.6) 
yes 207 (67.6) Advanced adenomas * 
no 99 (32.4) 
†2 missing values 
*Adenomas with villous component and/or severe dysplasia or carcinoma in situ  
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Table 2: Univariate analysis of compliance with colonoscopy among first-degree 
relatives of patients with large adenoma according to characteristics of first-degree 
relatives.  
 
Number of 
relatives 
Colonoscopies 
after index case 
diagnosis 
  n (%)    p* 
Gender    
men 306 49 (16)  
women  312 65 (21) 0.08 
Age     
<55 years 305 67 (22)  
≥55 years 313 47 (15) 0.02 
Relationship with index case    
parents 47 4 (9)  
siblings 390 69 (18) 0.08 
offspring 181 41 (23) 0.03 
Residence proximity with index case†    
Same area or bordering 323 76 (24)  
Other areas 214 38 (18) 0.36 
Total 618 114 (18.4)  
*: Obtained by Population Averaged logit models using Generalized 
Estimating Equations 
†: 81 missing values 
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Table 3: Univariate analysis of compliance with colonoscopy among first-degree 
relatives of patients with large adenoma according to characteristics of index 
cases*.  
 
Number 
of 
relatives
Colonoscopies 
after index case diagnosis 
  n (%)    p† 
Gender     
men 338 67 (20)  
women 280 47 (17) 0.35 
Age     
< 60 years 219 34 (16)  
≥ 60 years 399 80 (20) 0.29 
Residence area      
Greater Paris area 167 20 (12)  
other areas 451 94 (21) 0.03 
Family history of colorectal cancer 
yes 135 30 (22)  
no 483 84 (17) 0.36 
Personal history of polyps    
yes 90 23 (26)  
no 528 91 (17) 0.30 
Advanced adenomas ‡    
yes 445 80 (18)  
no 173 34 (20) 0.56 
Total 618 114 (19)  
* The characteristics of the index case were reported to all first-degree 
relatives of his/her family. 
† Obtained by Population Averaged logit models using Generalized 
Estimating Equations 
‡ Adenomas with villous component and/or severe dysplasia or carcinoma 
in situ 
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Table 4: Comparison of observed and expected colonoscopies among families 
under the assumption of absence of intra-familial correlation for acceptability 
Number of families Number of colonoscopies 
among families 
Expected Observed 
0 93 145 
1 104 44 
2 or more 21 29 
Total 218 
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